News in the Life Sciences Industry | |
Results 481 - 500 out of 500 displayed. | |
« 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 |
Valneva Announces Retirement of Chief Financial Officer David Lawrence |
Read more ›› |
By: GlobenewsWire - 18 Sep 2020 |
Dr. Jean-Christophe Rufin appointed President of the Sanofi Espoir Corporate Foundation |
Read more ›› |
By: GlobenewsWire - 18 Sep 2020 |
Setting new standards for speed and compatibility: Medit launches new T-Series scanner models |
SEOUL, South Korea, Sept. 17, 2020 /PRNewswire/ -- Medit announces the launch of three new T-Series laboratory scanner models; T710, T510, and T310. Read more ›› |
By: PR Newswire Association LLC. - 18 Sep 2020 |
New version - corrected 17 September, 2020 The results of Enzymatica's placebo-controlled, randomized study |
STOCKHOLM, Sept. 17, 2020 /PRNewswire/ -- Enzymatica distributed the press release about the result from its placebo-controlled, randomized study in Germany on August 17th. In this version the company referred incorrectly in the quote by Claus Egstrand that the results from the study confirmed... Read more ›› |
By: PR Newswire Association LLC. - 17 Sep 2020 |
Related companies: Enzymatica AB |
First patient in treatment in RhoVac's clinical phase IIb study in Sweden |
STOCKHOLM, Sept. 17, 2020 /PRNewswire/ -- RhoVac AB ("RhoVac") announces today, on September 17 2020, that the first patient in Sweden is enrolled in the company's clinical phase IIb study in prostate cancer, a study named RhoVac-002 ("BRaVac"). Read more ›› |
By: PR Newswire Association LLC. - 17 Sep 2020 |
Related companies: RhoVac AB |
Hansa Biopharma to host Capital Markets Day on Thursday October 29, 2020 in Copenhagen |
LUND, Sweden, Sept. 17, 2020 /PRNewswire/ -- Hansa Biopharma ("Hansa"), the leader in immunomodulatory enzyme technology for rare IgG mediated diseases, today announced that the Company will host its 2020 Capital Markets Day (CMD) in Copenhagen on Thursday October 29, from 13:30-17:30 CET (7:30am-11:30am... Read more ›› |
By: PR Newswire Association LLC. - 17 Sep 2020 |
Related companies: Hansa Biopharma AB |
INVISIO receives order for SEK 44 million from an existing customer in the U.S. |
STOCKHOLM, Sept. 17, 2020 /PRNewswire/ -- INVISIO has, through its U.S. GSA contract, received an order for SEK 44 million from an existing customer within the U.S. Department of Defense (DoD). The order includes advanced communication and hearing protection solutions. Delivery will be during... Read more ›› |
By: PR Newswire Association LLC. - 17 Sep 2020 |
Sectra signs enterprise imaging contracts with two top-rated health systems in US |
LINKÖPING, Sweden and SHELTON, Conn., Sept. 17, 2020 /PRNewswire/ -- International medical imaging IT and cybersecurity company Sectra... Read more ›› |
By: PR Newswire Association LLC. - 17 Sep 2020 |
Related companies: Sectra AB |
Aino Health AB (publ): Aino Health publishes memorandum and invites to an investor meeting |
Read more ›› |
By: GlobenewsWire - 16 Sep 2020 |
Related companies: Aino Health AB (publ) |
Diamyd Medical invites to a webcast presentation on September 17 on the results from DIAGNODE-2 |
STOCKHOLM, Sept. 16, 2020 /PRNewswire/ -- Diamyd Medical announced earlier this week that the diabetes vaccine Diamyd(®) has demonstrated significant effect in a subgroup which covers about half of all type 1 diabetes patients. In connection to this, CEO Ulf Hannelius together with the trial's... Read more ›› |
By: PR Newswire Association LLC. - 16 Sep 2020 |
Related companies: Diamyd Medical AB |
Looking for excellent, highly-skilled education and training in the vibrant field of Biophotonics? Apply now! |
STOCKHOLM, Sept. 16, 2020 /PRNewswire/ -- Apply to The European Training Network PHAST (Photonics for Healthcare: multiscAle cancer diagnosiS and Therapy). Maybe you will be one of 15 Early Stage Researchers (ESRs) which will be enrolled in a strong multidisciplinary PhD programme. Read more ›› |
By: PR Newswire Association LLC. - 16 Sep 2020 |
Related companies: SpectraCure AB |
New Clinical Studies show Improved Melanoma Detection by US clinicians with Nevisense |
STOCKHOLM, Sept. 16, 2020 /PRNewswire/ -- SciBase Holding AB ("SciBase") (STO:SCIB), a leading developer of augmented intelligence-based... Read more ›› |
By: PR Newswire Association LLC. - 16 Sep 2020 |
Related companies: SciBase AB |
Alligator Bioscience receives patent approval for the drug candidate ATOR-1015 |
LUND, Sweden, Sept. 16, 2020 /PRNewswire/ -- Alligator Bioscience (Nasdaq Stockholm: ATORX) announced today that the United States Patent and Trademark Office (USPTO) has issued U.S. Patent No. 10,774,150 which covers compositions of matter directed to Alligator's bispecific drug candidate... Read more ›› |
By: PR Newswire Association LLC. - 16 Sep 2020 |
Related companies: Alligator Bioscience AB |
Elekta introduces new radiotherapy solution to help address worldwide cancer burden |
- Elekta Harmony to shorten treatment times and reduce footprint while maintaining high precision Read more ›› |
By: PR Newswire Association LLC. - 15 Sep 2020 |
Related companies: Elekta AB |
Orexo commences patent infringement litigation against Sun Pharmaceutical |
UPPSALA, Sweden, Sept. 14, 2020 /PRNewswire/ -- Orexo AB (publ.), (STO:ORX) (OTCQX:ORXOY) today announces it has filed a patent infringement action in the United States District Court for the District of New Jersey with docket number 3:20-cv-12588, against Sun Pharmaceutical Industries... Read more ›› |
By: PR Newswire Association LLC. - 14 Sep 2020 |
Related companies: Orexo AB |
TIKOMED'S ILB® restores brain energy metabolism following severe traumatic brain injury in the rat demonstrated in data published by the journal Antioxidants |
VIKEN, Sweden, Sept. 14, 2020 /PRNewswire/ -- A new study on TIKOMED's lead drug candidate, ILB®, addressing one of the underlying causes of neurodegeneration in acute and chronic diseases was published in Antioxidants today. The data from the rodent model studying severe traumatic brain... Read more ›› |
By: PR Newswire Association LLC. - 14 Sep 2020 |
Related companies: TIKOMED AB |
TIKOMED'S ILB(R) restores brain energy metabolism following severe traumatic brain injury in the rat demonstrated in data published by the journal Antioxidants |
VIKEN, Sweden, Sept. 14, 2020 /PRNewswire/ -- A new study on TIKOMED's lead drug candidate, ILB®, addressing one of the underlying causes of neurodegeneration in acute and chronic diseases was published in Antioxidants today. The data from the rodent model studying severe traumatic brain... Read more ›› |
By: PR Newswire Association LLC. - 14 Sep 2020 |
Related companies: TIKOMED AB |
Implantica has resolved to shorten the application period of its ongoing offering due to high demand among investors |
STOCKHOLM, Sept. 14, 2020 /PRNewswire/ -- On 31 August 2020, Implantica AG([1]) ("Implantica", the "Company" or the "Group"), a medtech group with operations within the implantable medical device and eHealth markets, announced its intention to conduct an offering to the public of Swedish... Read more ›› |
By: PR Newswire Association LLC. - 14 Sep 2020 |
Phase IIb topline results demonstrate a significant treatment effect of Diamyd® in a previously identified genetic subgroup of individuals with type 1 diabetes |
STOCKHOLM, Sept. 14, 2020 /PRNewswire/ -- Diamyd Medical today announced the topline results from the placebo-controlled Phase IIb trial DIAGNODE-2, where the diabetes vaccine Diamyd(®) (GAD-alum) was injected directly into a lymph node in individuals with recently diagnosed type 1 diabetes.... Read more ›› |
By: PR Newswire Association LLC. - 14 Sep 2020 |
Related companies: Diamyd Medical AB |
Novo Nordisk A/S – Share repurchase programme |
Read more ›› |
By: GlobenewsWire - 14 Sep 2020 |
« 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 |
Upcoming Life Sciences Events
- January 2021
- NutrEvent
- AgeingFIT
- February 2021
- Swiss Nordic Bio 2021